Invasive candidiasis encompassing Candida bloodstream infections and deep-seated
candidiasis can become a persistent health problem. These infections are caused by …

Up to 1.5 million people die yearly from fungal disease, but the repertoire of antifungal drug
classes is minimal and the incidence of drug resistance is rising rapidly. This dilemma was …

Cryptococcosis caused by the Cryptococcus neoformans–Cryptococcus gattii complex is an
important opportunistic infection in people with immunodeficiency, including in the …

Invasive fungal diseases (IFD) are serious infections associated with high mortality,
particularly in immunocompromised patients. The prescribing of antifungal agents to prevent …

Nosocomial clusters of fungal infections, whilst uncommon, cannot be predicted and are
associated with significant morbidity and mortality. Here, we review reports of nosocomial …

Invasive fungal infections are increasingly encountered with the expansion of iatrogenic
immunosuppression, including not only solid organ and hematopoietic stem cell transplant …

Invasive fungal disease (IFD) remains a common and serious complication in children
treated for leukaemia. Antifungal prescription in children with leukaemia presents unique …

Candidiasis is a life-threatening disease that increases mortality in critically ill patients.
However, such epidemiological data are still lacking in underdeveloped regions of China. A …

Bloodstream infections caused by Candida yeasts (candidemia) are associated with high
morbidity and mortality. Diagnosis remains challenging, with the current gold standard …

The COVID-19 pandemic is associated with a significant increase in the incidence of
invasive mycosis, including pulmonary aspergillosis, mucormycosis, and candidiasis …